Skip to content

A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers

An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02628678
Enrollment
7
Registered
2015-12-11
Start date
2015-11-30
Completion date
2015-12-31
Last updated
2016-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Prebiotic, FOS, fructooligosaccharide, polyglycan, microbiome, microbiota, Healthy Volunteers

Brief summary

The primary objective of this study is to determine the 5-day tolerability of one commercially available prebiotic food ingredient, FOS, in healthy human subjects with and without diet control.

Interventions

DIETARY_SUPPLEMENTFOS

Sponsors

Kaleido Biosciences
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Be able to give written informed consent; 2. Be male or female of any race, between 18 and 65 years of age; 3. Have a BMI \> 20 & \< 27 kg/m2; 4. Be willing to follow a controlled low fiber diet for a period of 11 days;

Exclusion criteria

1. Are less than 18 and greater than 65 years of age; 2. Are hypersensitive to any of the components of FOS; 3. Are currently taking probiotic or prebiotic supplements, or have taken them in the past 28 days; 4. Unwilling to avoid probiotics/prebiotics supplements for the duration of the study; 5. Have a significant acute or chronic, unstable and untreated disease or any condition which contraindicates, in the investigators judgment, entry to the study; 6. Subject is a smoker; 7. Subject has a history of drug and/or alcohol abuse at the time of enrollment; 8. Taken a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results; 9. Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial; 10. Subjects may not be receiving treatment involving experimental drugs; 11. If the subject has been in a recent experimental trial, these must have been completed not less than 60 days prior to this study;

Design outcomes

Primary

MeasureTime frame
Number of subjects with Adverse Events22 days

Secondary

MeasureTime frame
The effect of controlling diet on the tolerability of FOS by analyzing the gut microbiome22 days

Other

MeasureTime frame
The effect of FOS on each subject's gut microbiome22 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026